Lilly completes acquisition of Centessa Pharmaceuticals to advance treatments for sleep-wake disorders
This story raises questions about governance, accountability, and American values.
Source: Eli Lilly; Company
1 min read
/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of Centessa Pharmaceuticals plc. Centessa is a
Original source:
Read at Eli Lilly; CompanyHow We See It
New Republican Times Editorial Board